Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia

被引:0
作者
Piacentini, Francesca [1 ]
Camera, Emanuela [1 ]
Di Nardo, Anna [1 ]
Dell'Anna, Maria Lucia [1 ]
机构
[1] San Gallicano Dermatol Inst IRCCS, Lab Cutaneous Physiopathol & Integrated Ctr Metabo, I-00144 Rome, Italy
关键词
seborrheic dermatitis; Malassezia; cytokine; inflammation; PIMECROLIMUS 1-PERCENT CREAM; DOUBLE-BLIND; 2-PERCENT CREAM; SKIN; IMMUNITY; MULTICENTER; INNATE; CELLS; PREVALENCE; ACTIVATION;
D O I
10.3390/ijms26062650
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Seborrheic dermatitis (SD) is a chronic inflammatory skin condition often involving the sebaceous-rich areas, characterized by erythematous scaly lesions. It is frequently observed in individuals with immune dysregulation, suggesting the interplay between the immune system and disease development. An altered immune environment leads to an exaggerated inflammatory response with the activation of innate immunity, involving the participation of mast cells, gamma delta T cells, and the NOD-LRR-pyrin-domain-containing protein 3 (NLRP3) inflammasome. This review aims to assess the complex relationship between Malassezia and the immune system in the pathogenesis of SD. We will explore how an impaired immune response predisposes the skin to Malassezia overgrowth and infection. We will examine the role of adaptive immunity, particularly T helper cells, in driving chronic inflammation in SD. All actors involved, whether part of innate or adaptive immunity, are responsible for the release of pro-inflammatory cytokines, which contribute to the progression of the disease. Therapeutic strategies aimed at the modulation of the immune response in SD have been tested in clinical trials evaluating the efficacy of immunomodulatory treatments in the management of SD. This review synthesizes insights from immunological studies and clinical trials to present an in-depth analysis of the immune mechanisms underpinning SD, thereby proposing targeted therapeutic strategies for its management.
引用
收藏
页数:14
相关论文
共 97 条
  • [1] An update on the microbiology, immunology and genetics of seborrheic dermatitis
    Adalsteinsson, Jonas A.
    Kaushik, Shivani
    Muzumdar, Sonal
    Guttman, Emma
    Ungar, Jonathan
    [J]. EXPERIMENTAL DERMATOLOGY, 2020, 29 (05) : 481 - 489
  • [2] Human leukocyte antigen system associations in Malassezia-related skin diseases
    Andersen, P. Lindso
    Jemec, G. B.
    Erikstrup, C.
    Didriksen, M.
    Dinh, K. M.
    Mikkelsen, S.
    Sorensen, E.
    Nielsen, K. R.
    Bruun, M. T.
    Hjalgrim, H.
    Hansen, T. F.
    Saekmose, S. G.
    Ostrowski, S. R.
    Saunte, D. M. L.
    Pedersen, O. B.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (04) : 895 - 902
  • [3] Ang-Tiu CU, 2012, EXPERT REV CLIN PHAR, V5, P91, DOI [10.1586/ecp.11.68, 10.1586/ECP.11.68]
  • [4] Barak-Shinar Deganit, 2017, J Clin Aesthet Dermatol, V10, P17
  • [5] Prevalence and related factors of psoriasis and seborrheic dermatitis: a community-based study
    Bas, Yalcin
    Seckin, Havva Yildiz
    Kalkan, Goknur
    Takci, Zennure
    Citil, Riza
    Onder, Yalcin
    Sahin, Safak
    Demir, Ayse Kevser
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (02) : 303 - 309
  • [6] Bergbrant IM, 1999, CLIN EXP DERMATOL, V24, P402, DOI 10.1046/j.1365-2230.1999.00512.x
  • [7] Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein
    Birnbaum, Ramon Y.
    Zvulunov, Alex
    Hallel-Halevy, Dafna
    Cagnano, Emanuella
    Finer, Gal
    Ofir, Rivka
    Geiger, Dan
    Silberstein, Eldad
    Feferman, Yael
    Birk, Ohad S.
    [J]. NATURE GENETICS, 2006, 38 (07) : 749 - 751
  • [8] γδ T cell effector functions: a blend of innate programming and acquired plasticity
    Bonneville, Marc
    O'Brien, Rebecca L.
    Born, Willi K.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (07) : 467 - 478
  • [9] Treatment of seborrheic dermatitis: a comprehensive review
    Borda, Luis J.
    Perper, Marina
    Keri, Jonette E.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 158 - 169
  • [10] Tacrolimus 0•1% ointment for seborrhoeic dermatitis:: an open-label pilot study
    Braza, TJ
    DiCarlo, JB
    Soon, SL
    McCall, CO
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (06) : 1242 - 1244